KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Cash from Operations: 2009-2025

Historic Cash from Operations for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $402.3 million.

  • Idexx Laboratories' Cash from Operations rose 82.82% to $402.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 18.68%. This contributed to the annual value of $929.0 million for FY2024, which is 2.48% up from last year.
  • Per Idexx Laboratories' latest filing, its Cash from Operations stood at $402.3 million for Q3 2025, which was up 116.61% from $185.7 million recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Cash from Operations peaked at $402.3 million during Q3 2025, and registered a low of $65.8 million during Q2 2022.
  • Over the past 3 years, Idexx Laboratories' median Cash from Operations value was $238.0 million (recorded in 2025), while the average stood at $242.0 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first spiked by 346.42% in 2021, then tumbled by 71.85% in 2022.
  • Over the past 5 years, Idexx Laboratories' Cash from Operations (Quarterly) stood at $210.0 million in 2021, then fell by 17.40% to $173.4 million in 2022, then spiked by 44.07% to $249.9 million in 2023, then rose by 4.87% to $262.0 million in 2024, then soared by 82.82% to $402.3 million in 2025.
  • Its Cash from Operations stands at $402.3 million for Q3 2025, versus $185.7 million for Q2 2025 and $238.0 million for Q1 2025.